Sep 6, 2008
Story Timeline: 127 days
Roche gets FDA okay for its Cobas TaqMan HBV test A Medical Device Daily Staff Report Roche Molecular Diagnostics (Pleasanton, California) reported FDA approval of the Roche Cobas TaqMan HBV Test, which the company said is the first assay for quantitating hepatitis B virus DNA to be approved in the U.S. The test uses Roche's real-time polymerase chain reaction (PCR) technology to quantify the amount of hepatitis...
[read full story]